-
Sanofi gets $43 million U.S. funding to spur Zika vaccine development
Sanofi SA said on Monday the U.S. Department of Health and Human Services (HHS) approved $43.18 million in funding to accelerate the development of a Zika vaccine, as efforts to prevent the infection gather momentum.
- Categories
- Health Care
-
Bee Pharma Africa and a Flying Pharmacy
Hugo Fearnley of Whitby, England is studying the potential of bee-produced medicinesfor the treatment of human diseases. Fearnley, CEO of BeeVital and Director of theApiceutical Research Centre (ARC), recently earned a Churchill Travelling Fellowship to fund his research and coalition-building in four African countries.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Quest Diagnostics Launches Zika Antibody Test Created by CDC
Quest Diagnostics announced a new antibody test service — based on the Zika immunoglobulin M antibody capture enzyme-linked immunosorbent assay developed by the CDC — is available for the detection of infection associated with Zika virus, according to a news release.
- Categories
- Health Care
-
Micro-Health insurance Startup Wins Seedstars Dar es Salaam
Mobile micro-health insurance startup Jamii has been named Tanzania’s best startup at the Seedstars Dar es Salaam pitching competition, and will represent the country at the global finals to be held in Switzerland in March 2017.
- Categories
- Health Care
-
GSK Pledges to Drop Vax Price for Refugees
GlaxoSmithKline will discount the price of its pneumococcal vaccine to $3.05 per dose for charities which work to immunize refugees and displaced people. The price reduction for Synflorix is the first step in a broader pledge to supply essential vaccines to civil society organizations at lower prices.
- Categories
- Health Care
- Tags
- vaccines
-
Expanding to Africa, Columbia Pacific Opens Health Clinic in Nairobi
Columbia Pacific Management, a Seattle-based investment firm that runs health-care facilities in various countries, has expanded to Africa.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
A New Technique May Democratise Vaccine Production
Making vaccines often involves growing bugs—and these days the bugs in question are frequently genetically modified. There are, with good reason, strict regulations about the use and transport of such modified organisms, for fear that something bad might escape and thrive in the wild. And this has led to vaccine-producing bugs being grown in secure, centralised “foundries”, whence their products are distributed to the wider world.
- Categories
- Health Care
- Tags
- vaccines
-
Viewpoint: The Next Big Idea May Be Growing Far From Silicon Valley
Facebook CEO Mark Zuckerberg made his first trip to Africa this summer with stops in Nigeria and then Kenya. In June, the Chan Zuckerberg initiative—the philanthropic foundation of Zuckerberg and his wife Dr. Priscilla Chan—invested $24 million in Andela, a company that trains top software developers in Kenya and Nigeria. This trip and investment is a departure from the prevailing mindset in Silicon Valley, where top venture capital firms are investing in companies making products and services—like monthly deliveries of cannabis products or on-demand set-up of personal karaoke parties—to address increasingly minor “first world” problems with some of the country’s best talent.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- philanthropy
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.